Joshua M. Uronis - Concepedia

Author

Joshua M. Uronis

University of North Carolina at Chapel Hill ORCID

Also Known As

Arthur, Janelle C., Fodor, Anthony A., Holl, Eda K., J. M. Uronis, Jobin, Christian, Jones, Gieira S., Joshua M Uronis, Joshua M. Uronis, Joshua Uronis, Joshua M. Uronis

100

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of North Carolina at Charlotte UNC Lineberger Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center University of Florida

About

Joshua M. Uronis is an author at University of North Carolina at Chapel Hill specializing in medicine, pathology, and colorectal cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.7K
2	Immunology	4	4	1.2K
3	Cell Biology	3	3	638
4	Gastroenterology	2	2	462
5	Biology	1	1	19

Joshua M. Uronis

Publications

Citations

H-Index

Page 1

	Year	Citations
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota Janelle C. Arthur, Ernesto Peréz-Chanona, Marcus Mühlbauer, Science	2012	2.2K
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer Irving C. Allen, Erin McElvania, Rita-Marie T. Woodford, The Journal of Experimental Medicine	2010	804
NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB Signaling Irving C. Allen, Justin E. Wilson, Monika Schneider, Immunity InflammationMucosal ImmunologyNoncanonical Nf-κb SignalingImmune RegulationImmunology	2012	544
Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility Joshua M. Uronis, Marcus Mühlbauer, Hans Herfarth, PLoS ONE InflammationDysbiosisGut MicrobiologyGastroenterologyPathology	2009	419
Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer Janelle C. Arthur, Raad Z. Gharaibeh, Marcus Mühlbauer, Nature Communications DysbiosisEssential RoleGut MicrobiologyColorectal CancerPathology	2014	391
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience Tracy L. Rose, William H. Weir, Gregory M. Mayhew, British Journal of Cancer Checkpoint InhibitionUrologyMetastatic Urothelial CancerGenitourinary CancerImmunology	2021	185
VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer Janelle C. Arthur, Raad Z. Gharaibeh, Joshua M. Uronis, Scientific Reports	2013	119
Protein Kinase C Signaling Mediates a Program of Cell Cycle Withdrawal in the Intestinal Epithelium Mark R. Frey, Jennifer A. Clark, Olga V. Leontieva, The Journal of Cell Biology	2000	113
Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis Joshua M. Uronis, Janelle C. Arthur, Temitope O. Keku, Inflammatory Bowel Diseases	2010	102
Histological and Molecular Evaluation of Patient-Derived Colorectal Cancer Explants Joshua M. Uronis, Takuya Osada, Shannon J. McCall, PLoS ONE Tumor HeterogeneityMedicineColorectal CancerPathologyMouse Models	2012	56

Page 1